go-v.orgdoi

Alzheimer's disease biomarkers: their value in diagnosis and clinical trials

H. Small David · Frontiers in bioscience · 2002

  • DOI 10.2741/small
  • Publisher Frontiers in Bioscience
  • Type article
  • Issued 2002

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Frontiers in bioscience · Frontiers in Bioscience · article · 2002

Abstract

Biomarkers of Alzheimer's disease may be useful, not only for early diagnosis of the disease, but also for monitoring the progress of drug trials. A number of plasma and cerebrospinal fluid markers are reportedly altered in Alzheimer's disease. So far, no single biomarker can be used to diagnose Alzheimer's disease definitively. Nevertheless, it may eventually be possible to use several markers in combination to obtain sufficient diagnostic accuracy. However, for this to be the case, new specific biomarkers may need to be identified.

Open the resolved locator · 10.2741/small

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 00:32 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://doi.org/10.2741/small
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.